Correction to: Oncogenesis (2017) 6, e389; doi:10.1038/oncsis.2017.87; Published online 9 October 2017
The legend of Figure 5 was published incorrectly. The correct legend should read as follows:
Figure 5. Association between ESRP1 gene expression and OS or PFS in patients with ovarian serous adenocarcinoma. (a, b) Kaplan–Meier plot of 5-year OS, and PFS in total primary tumors and (c, d) stage III primary tumors. Patients were divided into two groups based on ESRP1 expression, ESRP1 low expression (ESRP1-low) and ESRP1 high expression (ESRP1-high) groups. The statistical difference in the survival between the two groups was tested with the log-rank test. The number of patients for each group is provided in parentheses.
This error has now been rectified and the corrected article appears in this issue together with this corrigendum.
The publishers wish to apologise for any inconvenience caused.
Additional information
The online version of the original article can be found at 10.1038/oncsis.2017.87
Rights and permissions
Oncogenesis is an open-access journal published by Nature Publishing Group. This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
About this article
Cite this article
Jeong, H., Han, J., Lee, S. et al. Erratum: ESRP1 is overexpressed in ovarian cancer and promotes switching from mesenchymal to epithelial phenotype in ovarian cancer cells. Oncogenesis 6, e391 (2017). https://doi.org/10.1038/oncsis.2017.89
Published:
Issue Date:
DOI: https://doi.org/10.1038/oncsis.2017.89
This article is cited by
-
Expression profile of RNA binding protein in cervical cancer using bioinformatics approach
Cancer Cell International (2021)
-
Circ-NOLC1 promotes epithelial ovarian cancer tumorigenesis and progression by binding ESRP1 and modulating CDK1 and RhoA expression
Cell Death Discovery (2021)
-
Identification of an RNA binding protein-related gene signature in hepatocellular carcinoma patients
Molecular Medicine (2020)
